The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lansen Pharmaceutical Holdings - Update

1 Jun 2010 07:06

RNS Number : 8165M
Cathay International Holdings Ld
01 June 2010
 



1 June 2010

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA.

 

THE CONTENTS OF THIS ANNOUNCEMENT DO NOT CONSTITUTE OR FORM PART OF AN OFFER OF OR INVITATION TO SELL OR ISSUE OR ANY SOLICITATION OF ANY OFFER TO PURCHASE OR SUBSCRIBE FOR ANY SECURITIES FOR SALE IN ANY JURISDICTION NOR SHALL THEY (OR ANY PART OF THEM) OR THE FACT OF THEIR DISTRIBUTION FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, OR ACT AS AN INDUCEMENT TO ENTER INTO, AND CONTRACT OR COMMITMENT TO DO SO.

 

CATHAY INTERNATIONAL HOLDINGS LTD.

 

Update on Flotation and Partial Disposal of

Lansen Pharmaceutical Holdings Company Limited ("Lansen Holdings")

 

Cathay International Holdings Ltd. (LSE: CTI.L) (the "Company"), the London listed company specialising in investment opportunities in the People's Republic of China ("PRC"), announces that, further to the announcement made by the Company on 6 May 2010 and following the commencement of trading of shares in Lansen Holdings on 7 May 2010, the stabilisation period in connection with the flotation of Lansen Holdings ended on 30 May 2010. 

 

On 28 May 2010, Piper Jaffray Asia Securities Limited, as sole bookrunner on behalf of the placing underwriters, exercised the over-allocation option granted to it under the terms of the flotation, and Lansen Holdings will issue 15,000,000 shares in order to cover the over-allocations in the placing carried out in connection with the flotation of Lansen Holdings (the "Over-allocation Shares"). Lansen Holdings will receive additional net proceeds of approximately HK$56 million (approximately US$7.2 million) from the allotment and issue of the Over-allocation shares in Lansen Holdings.

 

Following the allotment of the Over-allocation Shares, the Company will hold approximately 50.56% of the enlarged share capital of Lansen Holdings.

 

Enquiries

 

Cathay International Holdings Ltd.

+ 852 2828 9289

Patrick Sung / Eric Siu

Brunswick

+44 (0)20 7404 5959

Jon Coles

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGLGDLSGGBGGB
Date   Source Headline
30th Aug 201911:33 amRNSInterim Results
27th Aug 20194:10 pmRNSLansen reports interim results ended 30 June 2019
16th Aug 201911:46 amRNSNotice of Interim Results
1st Aug 20199:52 amRNSBlock listing Interim Review
25th Jul 201911:34 amRNSTrading Update
12th Jul 20199:24 amRNSChange of Registered Office Address in Bermuda
8th Jul 201912:32 pmRNSUpdate on cross guarantee agreement
28th Jun 20197:00 amRNSTotal Voting Rights
21st Jun 201911:56 amRNSUpdate re Natural Dailyhealth
21st Jun 201910:58 amRNSStatement relating to UK FCA enforcement action
20th Jun 201912:01 pmRNSUpdate on renewal of Cross Guarantee Agreement
12th Jun 201912:02 pmRNSChange of Company Secretary
12th Jun 201911:59 amRNSUpdate on renewal of Cross Guarantee Agreement
11th Jun 201911:41 amRNSDisposal of Starry Shares
10th Jun 20194:08 pmRNSResult of AGM
31st May 201910:51 amRNSStatement relating to UK FCA enforcement action
14th May 201911:54 amRNSDisposal of Starry Shares
3rd May 20192:24 pmRNSRenewal of Cross Guarantee
24th Apr 201912:23 pmRNSStarry Share Disposal
12th Apr 20199:42 amRNSResult of Special General Meeting
29th Mar 201912:49 pmRNSAnnual Results For the Year Ended 31 December 2018
27th Mar 20194:59 pmRNSProposed Further Disposal of Starry Shares
27th Mar 20198:01 amRNSLansen reports annual results
15th Mar 20197:00 amRNSNotice of Annual Results 2018
22nd Feb 20199:32 amRNSBlock listing Interim Review - Replacement
20th Feb 20193:24 pmRNSLansen's fourth share reduction plan of Starry
1st Feb 201910:52 amRNSBlock listing Interim Review
1st Feb 201910:45 amRNSTotal Voting Rights
25th Jan 20199:59 amRNSLansen's release of its Trading Update
31st Dec 20187:00 amRNSInvestment by Lansen in Robustnique
18th Dec 20188:02 amRNSTrading Update
30th Nov 20189:34 amRNSProposed Starry Shares Disposal by Lansen
12th Oct 201810:31 amRNSChange Of Director
20th Sep 20189:43 amRNSHolding(s) in Company
31st Aug 20189:47 amRNSInterim Results
28th Aug 20182:28 pmRNSLansen reports interim results
17th Aug 20187:00 amRNSNotice of Interim Results 2018
13th Jul 20189:11 amRNSTrading Update
4th Jul 20189:05 amRNSSecond Price Monitoring Extn
4th Jul 20189:00 amRNSPrice Monitoring Extension
25th Jun 20188:00 amRNSExtension of put option in Natural Dailyhealth
6th Jun 20181:25 pmRNSLansen's partial disposal of shares in Starry
5th Jun 20189:22 amRNSResults of Annual General Meeting
2nd May 201811:20 amRNSLansen subsidiary enters distribution agreement
16th Apr 201812:43 pmRNSLansen's shareholder loan to Natural Dailyhealth
9th Apr 201811:33 amRNSAnnual Results for the Year Ended 31 December 2018
3rd Apr 201810:14 amRNSLansen's third share reduction plan of Starry
27th Mar 20189:59 amRNS2017 Lansen Annual Results
15th Mar 20187:00 amRNSNotice of Results
9th Feb 20187:43 amRNSLansen appoints Executive Director & Group CEO

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.